B3GALT1


b3galt1: A Key Regulator in Glycoprotein Synthesis and Human Health

Description

Beta-1,3-galactosyltransferase 1 (b3galt1) is an enzyme that plays a crucial role in the synthesis of glycoproteins, which are molecules that combine proteins with carbohydrate chains. b3galt1 specifically adds galactose sugars to the third carbon atom of N-acetylglucosamine residues in oligosaccharides, a type of carbohydrate found in glycoproteins. This process is essential for the proper function of glycoproteins, which are involved in a wide range of biological processes, including cell-cell communication, cell adhesion, and immune recognition.

Associated Diseases

Mutations in the b3galt1 gene have been linked to several human diseases, including:

  • Congenital Disorder of Glycosylation Type IIe (CDG-IIe): A rare genetic disorder characterized by severe developmental delay, dysmorphic features, and neurological abnormalities.
  • Muscular Dystrophy-Dystroglycanopathy Complex (MDDGC): A group of inherited neuromuscular disorders caused by defects in the dystroglycan complex, which is involved in maintaining the structural integrity of muscle fibers.
  • Walker-Warburg Syndrome (WWS): A severe genetic disorder characterized by hydrocephalus, developmental delay, and muscular dystrophy.
  • Fukuyama Muscular Dystrophy (FCMD): A rapidly progressive muscular dystrophy that affects young children and is characterized by muscle weakness, respiratory problems, and cognitive difficulties.

Did you Know ?

  • Mutations in the b3galt1 gene account for approximately 10-20% of cases of CDG-IIe, one of the most common types of congenital disorders of glycosylation.


Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.